中危小主动脉瓣环患者无支架瓣膜与经导管瓣膜早期血流动力学及临床结局比较
该多中心研究通过倾向性匹配分析比较了中危(STS评分4-10)且主动脉瓣环≤23 mm患者行孤立性外科主动脉瓣置换术使用Freedom SOLO无支架瓣膜(FS)与经导管主动脉瓣置换术(TAVR)的早期结局。结果显示两组血流动力学表现相似,但TAVR组院内死亡率和永久起搏器植入率更高。
要点
- 中危小瓣环患者中FS与TAVR血流动力学表现相当。
- TAVR组院内死亡率(6.3%)高于FS组(2.1%)。
- TAVR组永久起搏器植入率(12%)显著高于FS组(0.7%)。
核心结论
- 在中危且小主动脉瓣环患者中,FS和TAVR均表现出相似且优异的血流动力学性能,但TAVR的死亡率和起搏器植入率更高。
研究设计与样本
- 多中心研究,纳入2010至2014年接受孤立性外科主动脉瓣置换术的FS患者420例和TAVR患者375例,筛选出中危(STS评分4-10)且小瓣环(≤23 mm)患者,经倾向性匹配后每组各142例进行分析。
主要发现
- 两组均无人工瓣膜-患者不匹配。
- TAVR组术后2-3级瓣周漏发生率为3.5%,FS组为0.7%。
临床怎么用
- 对于中危且小主动脉瓣环的主动脉瓣病变患者,选择FS或TAVR时需权衡血流动力学获益与TAVR较高的死亡率和起搏器植入风险。
局限性
- 需进一步研究验证TAVR在该类患者中的适应证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stentless aortic valves have been developed to overcome obstructive limitations associated with stented bioprostheses. The aim of the current multi-institutional study was to compare hemodynamics of transcatheter (TAVR) and the Freedom SOLO Stentless (FS) valve in an intermediate risk population undergoing surgical aortic valve replacement. METHODS: From 2010 to 2014, 420 consecutive patients underwent isolated surgical aortic valve replacement with FS and 375 patients underwent TAVR. Only patients with intermediate operative risk (Society of Thoracic Surgeons score 4-10) and small aortic annulus (≤23 mm) were included. After a propensity matched analysis 142 patients in each group were selected. Thirty-day postoperative clinical and echocardiographic parameters were evaluated. RESULTS: Mean prosthesis diameter was 22.2 ± 0.9 mm for FS and 22.4 ± 1.0 mm for TAVR. In-hospital mortality was 2.1% for FS and 6.3% for TAVR (P = .02). Postoperative FS peak gradients were 19.1 ± 9.6 mm Hg (mean 10.8 ± 5.9 mm Hg); TAVR peak gradients were 20.2 ± 9.5 mm Hg (mean 10.7 ± 6.9 mm Hg) P = .57 (P = .88). Postoperative effective orifice area was 1.93 ± 0.52 cm2 for FS and 1.83 ± 0.3 cm2 for TAVR (P = .65). There was no prostheses-patient mismatch in either group. Postoperative grade 2-3 paravalvular leak was present in 3.5% for TAVR and 0.7% for FS. Postoperative permanent pacemaker implant rate was 12% for TAVR and only 1 case (0.7%) in the FS group (P < .001). CONCLUSIONS: In patients with small aortic annulus and intermediate risk, both FS and TAVR demonstrated similar excellent hemodynamic performance. TAVR demonstrated greater mortality and rates of pacemaker insertion. Further studies are warranted to validate TAVR indications in this subset of patients.
引用
- Repossini A, Di Bacco L, Passaretti B, et al. Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients. J Thorac Cardiovasc Surg. 2016. PMID: 27939031. doi:10.1016/j.jtcvs.2016.10.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。